Android app Apple app link

Applied Therapeutics Receives FDA Complete Response Letter for Govorestat New Drug Application

By MarketWatch   |   1 year ago
Applied Therapeutics Receives FDA Complete Response Letter for Govorestat New Drug Application

Applied Therapeutics received a complete response letter from the FDA regarding their new drug application for govorestat due to clinical deficiencies. The stock dropped 16% in post-market trading. The company plans to review the feedback and potentially resubmit the NDA for the treatment of galactosemia.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.